Business leaders and investors remain on edge ahead of President Trump’s expected announcement of a sweeping new round of ...
Isomorphic Labs was founded to apply artificial intelligence to drug discovery. The company is led by AI researcher Sir Demis Hassabis.
Google DeepMind launches TxGemma, open AI models to speed up drug discovery, enhance predictions, and support multi-step ...
Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...
Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...
AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...
The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
The funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.
Yutori wants to bring AI into the workplace by creating a digital personal assistant that can actually do some work for you ...
Isomorphic Labs, the drug discovery start-up spun out of Google’s DeepMind artificial intelligence unit, has raised $600mn in its first external funding round, as investors bet on the potential for AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results